The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients

References

• Brekke M, Rognstad S, Straand J, et al. Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Baseline data from the Prescription Peer Academic Detailing (Rx-PAD) study. Scand J Prim Health Care 2008; 26: 80–5
   PubMed Web of Science ®Google Scholar
• Curtis LH, Ostbye T, Sendersky V, et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004; 164: 1621–5
   PubMed Web of Science ®Google Scholar
• Straand J, Rokstad KS. Elderly patients in general practice: Diagnoses, drugs and inappropriate prescriptions. A report from the More & Romsdal Prescription Study. Fam Pract 1999; 16: 380–8
   PubMed Web of Science ®Google Scholar
• Kadam UT, Jordan K, Croft PR. A comparison of two consensus methods for classifying morbidities in a single professional group showed the same outcomes. J Clin Epidemiol 2006; 59: 1169–73
   PubMed Web of Science ®Google Scholar
• Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000; 321: 425–8
   PubMed Web of Science ®Google Scholar
• Campbell SM, Cantrill JA. Consensus methods in prescribing research. J Clin Pharm Ther 2001; 26: 5–14
   PubMed Web of Science ®Google Scholar
• Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825–32
   PubMed Web of Science ®Google Scholar
• Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: An update. Arch Intern Med 1997; 157: 1531–6
   PubMed Web of Science ®Google Scholar
• Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24
   PubMed Web of Science ®Google Scholar
• O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: Need for new criteria. Age Ageing 2008; 37: 138–41
   PubMed Web of Science ®Google Scholar
• Swedish National Board of Health and Welfare. Indikatorer för utvärding av kvaliteten i äldres läkmedelsterapi, [Indicators for assessing the quality of the medication of elderly patients]. Stockholm: Socialstyrelsen; 2003.
   Google Scholar
• Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: What are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003; 12: 176–80
   PubMedGoogle Scholar
• Aizenberg D, Sigler M, Weizman A, Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr 2002; 14: 307–10
   PubMed Web of Science ®Google Scholar
• K Baxter. Stockley's drug interactions. 7th ed. London: The Pharmaceutical Press; 2006.
   Google Scholar
• Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Intern Med 2003; 163: 59–64
   PubMed Web of Science ®Google Scholar
• Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 2007; 177: 347–51
   PubMed Web of Science ®Google Scholar
• Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004; 292: 2585–90
   PubMed Web of Science ®Google Scholar
• Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998; 158: 1108–12
   PubMed Web of Science ®Google Scholar
• Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005; 165: 1095–106
   PubMed Web of Science ®Google Scholar
• Katzung Bertram G. Basic and clinical pharmacology10th ed. McGraw Hill, San Franscisco 2007
   Google Scholar
• Koski K, Luukinen H, Laippala P, Kivela SL. Physiological factors and medications as predictors of injurious falls by elderly people: A prospective population-based study. Age Ageing 1996; 25: 29–38
   PubMed Web of Science ®Google Scholar
• Kurisu S, Inoue I, Kawagoe T, et al. Role of medications in symptomatic hyperkalemia. QJM 2007; 100: 591–3
   PubMed Web of Science ®Google Scholar
• Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk for falls among community-dwelling frail older people: An observational study. J Gerontol A Biol Sci Med Sci 2005; 60: 622–6
   PubMed Web of Science ®Google Scholar
• Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: A systematic review and meta-analysis, I: Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30–9
   PubMed Web of Science ®Google Scholar
• Loke YK, Trivedi AN, Singh S. Meta-analysis: Gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008; 27: 31–40
   PubMed Web of Science ®Google Scholar
• McClure DL, Valuck RJ, Glanz M, et al. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol 2007; 60: 812–18
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Blot WJ, Sorensen HT, et al. Upper gastrointestinal bleeding among users of NSAIDs: A population-based cohort study in Denmark. Br J Clin Pharmacol 2002; 53: 173–81
   PubMed Web of Science ®Google Scholar
• Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15: 15–28
   PubMed Web of Science ®Google Scholar
• Pal D, Mitra AK. MDR- and CYP3A4-mediated drug–drug interactions. J Neuroimmune Pharmacol 2006; 1: 323–39
   PubMed Web of Science ®Google Scholar
• Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25: 61–70
   PubMed Web of Science ®Google Scholar
• Schepkens H, Vanholder R, Billiouw JM, Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: An analysis of 25 cases. Am J Med 2001; 110: 438–41
   PubMed Web of Science ®Google Scholar
• Verhamme KM, Dieleman JP, Van Wijk MA, et al. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention. Arch Intern Med 2005; 165: 1547–51
   PubMedGoogle Scholar
• Witczak BJ, Asberg A, Hartmann A. [Acute dialysis-dependent renal failure at the Rikshospital in 1998]. Tidsskr Nor Laegeforen 2001; 121: 1216–19
   PubMedGoogle Scholar
• Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008; 168: 508–13
   PubMed Web of Science ®Google Scholar
• Greatorex J, Dexter T. An accessible analytical approach for investigating what happens between the rounds of a Delphi study. J Adv Nurs 2000; 32: 1016–24
   PubMed Web of Science ®Google Scholar
• Tata LJ, Fortun PJ, Hubbard RB, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?. Aliment Pharmacol Ther 2005; 22: 175–81
   PubMed Web of Science ®Google Scholar
• Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000; 32: 1008–15
   PubMed Web of Science ®Google Scholar
• Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ 2003; 326: 816–19
   PubMed Web of Science ®Google Scholar
• Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: Characteristics and guidelines for use. Ann Intern Med 1984; 74: 979–83
   Google Scholar
• Rasmussen HM, Sondergaard J, Kampmann JP, Andersen M. General practitioners prefer prescribing indicators based on detailed information on individual patients: A Delphi study. Eur J Clin Pharmacol 2005; 61: 237–41
   PubMed Web of Science ®Google Scholar
• Williams D, Bennett K, Feely J. The application of prescribing indicators to a primary care prescription database in Ireland. Eur J Clin Pharmacol 2005; 61: 127–33
   PubMed Web of Science ®Google Scholar
• Skoglund I, Segesten K, Bjorkelund C. GPs’ thoughts on prescribing medication and evidence-based knowledge: The benefit aspect is a strong motivator. A descriptive focus group study. Scand J Prim Health Care 2007; 25: 98–104
   PubMed Web of Science ®Google Scholar